DYSF and sarcoma: While penetrance was sharply increased in male mice, 63% of which developed sarcomas, a dramatic decrease in tumor latency was observed in both genders, with the mean age-of-onset reduced to ∼390 d (compared to 540 d in Dmd −/− and 640 d in Dysf −/−).